Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21

Trial Status

Recruiting1
Other1

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT06801236Phase 1Recruiting
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
mCRPC (Metastatic Castration-resistant Prostate Cancer)Prostate Cancer (Adenocarcinoma)
StudydirectorStart date: 2025-05-12
NCT06380660Phase 1/2Active Not Recruiting
Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors
BRCA1 MutationBRCA2 MutationBreast Cancer+3 more
StudydirectorStart date: 2024-03-22

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT06801236Phase 1StudyDirector

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

mCRPC (Metastatic Castration-resistant Prostate Cancer)Prostate Cancer (Adenocarcinoma)
Recruiting
NCT06380660Phase 1/2StudyDirector

Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors

BRCA1 MutationBRCA2 MutationBreast Cancer+3 more
Active Not Recruiting

All 2 trials loaded